Your browser doesn't support javascript.
loading
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.
Alenazy, Fawaz O; Harbi, Maan H; Kavanagh, Dean P; Price, Joshua; Brady, Paul; Hargreaves, Oscar; Harrison, Paul; Slater, Alexandre; Tiwari, Alok; Nicolson, Phillip L R; Connolly, Derek L; Kirchhof, Paulus; Kalia, Neena; Jandrot-Perrus, Martine; Mangin, Pierre H; Watson, Steve P; Thomas, Mark R.
  • Alenazy FO; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
  • Harbi MH; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Kavanagh DP; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Price J; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Brady P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, United Kingdom.
  • Hargreaves O; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Harrison P; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
  • Slater A; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Tiwari A; Department of Vascular Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Nicolson PLR; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Connolly DL; Department of Cardiology, Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, United Kingdom.
  • Kirchhof P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, University Heart and Vascular Center (UKE) Hamburg, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany.
  • Kalia N; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Jandrot-Perrus M; UMR_S1148, INSERM, Paris, France.
  • Mangin PH; UMR_S1255, INSERM, Etablissement Francais du Sang-Alsace, Strasbourg, France.
  • Watson SP; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands, United Kingdom.
  • Thomas MR; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, United Kingdom; Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust
J Thromb Haemost ; 21(11): 3236-3251, 2023 11.
Article en En | MEDLINE | ID: mdl-37541591
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombosis / Síndrome Coronario Agudo / Placa Aterosclerótica / Infarto del Miocardio con Elevación del ST Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombosis / Síndrome Coronario Agudo / Placa Aterosclerótica / Infarto del Miocardio con Elevación del ST Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article